ALECENSA was able to shrink the size of tumors in nearly 80% of people with ALK+ mNSCLC. At the first assessment, the IRC evaluated the ability of ALECENSA to shrink the size of tumors in people with ALK+ mNSCLC. It is important to know that a complete response does not mean the cancer has been cured.
Additional Information
Payment Terms
Western Union,
Port of DispatchInidia
Packaging DetailsBox
Delivery Time05-12days
Interested in this product? Ask for more details & Latest Price from seller
We are base Exporters from India, we provide you with the best medication(s), we ship worldwide. Our employers genuinely cares for your growth, both professionally and personally. Thanks for shopping with us.
Nature of Business Manufacturer / Exporter / Supplier / Trader
Number of Employees100 - 150
Year of Establishment1981
Tell us your Buy Requirement to Get Instant Response